Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Iron Deficiencies 1Anemia 1

Interventions

Epoetin Alfa 8ferric carboxymaltose 6epoetin beta 6Darbepoetin alfa 4ferrous sulfate 2ferrous fumarate 2Radiotherapy 2iron isomaltoside 1000 1ferrous succinate 1ferric gluconate 1Vitamin B 12 1Thiotepa 1Standard of Care 1Hematinics 1Folic Acid 1Filgrastim 1Erythropoietin 1Cyclophosphamide 1Cisplatin 1Cholecalciferol 1Brachytherapy 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Anemia × ferric gluconate × Clear all
NCT00224068 2012-03-02

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Watson Pharmaceuticals

Phase 4 Completed
180 enrolled
Classical hematology

Iron Deficiencies, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡